MedPath

Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden

Not yet recruiting
Conditions
Atrial Fibrillation (AF)
Registration Number
NCT06686940
Lead Sponsor
Beijing Anzhen Hospital
Brief Summary

The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  1. Atrial fibrillation patients diagnosed by electrocardiogram
  2. Willing to use long-range electrocardiogram monitoring equipment
Exclusion Criteria

1.Patients who are allergic to electronic devices or unable to wear watches

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomeDecember 30, 2024 to Decemberr 30, 2034

all-cause death, cardiovascular death, myocardial infarction, heart failure, stroke, peripheral vascular disease, recurrence of atrial fibrillation diagnosed by electrocardiogram, palpitations symptoms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beijing Anzhen Hospital

🇨🇳

Beijing, Beijing, China

Beijing Anzhen Hospital
🇨🇳Beijing, Beijing, China
Song Zuo, M.D
Contact
1880142775
song_zuo@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.